Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
ABCD1
16%
ABCD2
33%
Antioxidant Effect
100%
ATP-binding Cassette Transporter A1 (ABCA1)
16%
Clinical Investigation
16%
Demyelinating
16%
Early Events
16%
Hexacosanoic Acid
16%
Histone Deacetylase Inhibitor (HDACi)
16%
Long-chain Polyunsaturated Fatty Acids (LC-PUFA)
66%
Loss Function
16%
Metabolism
16%
Monounsaturated
16%
Mouse Model
16%
Neurodegeneration
16%
Neurometabolic Disease
16%
Novel Therapeutics
16%
Overexpression
16%
Oxidative Damage
50%
Oxidative Lesions
16%
Peripheral Blood Mononuclear Cells
16%
Peroxisomal
33%
Valproic Acid
100%
X-linked Adrenoleukodystrophy (X-ALD)
100%
Neuroscience
ABC Transporter Subfamily D
16%
Adrenoleukodystrophy
100%
Anticonvulsant
16%
Antioxidant
100%
Histone Deacetylase Inhibitor
16%
Metabolic Pathway
16%
Neurometabolic Disease
16%
Peripheral Blood Mononuclear Cell
16%
Valproic Acid
100%
Very Long Chain Fatty Acid
66%
Biochemistry, Genetics and Molecular Biology
ABC Transporter
16%
ABCD1
16%
ABCD2
33%
Adrenoleukodystrophy
100%
ATP-binding Cassette Transporter
16%
Histone Deacetylase
16%
Metabolic Pathway
16%
Mouse Model
16%
Peripheral Blood Mononuclear Cell
16%
Revertant
16%
Very Long Chain Fatty Acid
66%